查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620650

個人化醫療市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Personalized Medicine Market by Product (Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), Application (Antiviral, Cardiology, Immunology), End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年個人化醫療市場價值為5421億美元，預計到2024年將達到5755億美元，複合年成長率為6.67%，預計到2030年將達到8520.2億美元。

個人化醫療 (PM) 是醫療保健領域的一種變革性方法，重點是根據個人的遺傳、環境和生活方式因素量身定做治療方案。其範圍涵蓋基因組學、藥物基因組學和對於制定準確治療計劃至關重要的高級診斷學。隨著患者對客製化治療解決方案的需求不斷增加、慢性病盛行率的增加以及體學技術的進步，對個人化醫療的需求也在不斷成長。應用領域涵蓋從腫瘤學（標靶治療為癌症患者帶來新希望）到心血管疾病和罕見遺傳疾病，每種疾病都從這種個人化方法中受益匪淺。最終用途領域包括醫院、診斷實驗室和研究機構，所有這些機構都利用 PM 來改善治療結果和業務效率。

主要市場統計
基準年[2023] 5421億美元
預計年份 [2024] 5755億美元
預測年份 [2030] 8520.2億美元
複合年成長率（%） 6.67%

加速市場成長的關鍵因素包括技術進步、研發投資以及促進精準醫療計畫的有利法規結構。然而，也存在一些挑戰，例如基因序列測定的高成本、對資料隱私的擔憂以及將預防醫學融入傳統醫療實踐的複雜性。新的機會也比比皆是，例如將人工智慧和機器學習整合到處理大型資料集集以發現生物標記物，這可以提高預測準確性和治療效果。

創新研究領域包括開發具有成本效益的定序技術和研究微生物組對藥物基因組學的影響。公司可以透過投資結合PM和遠端醫療的數位健康解決方案來競爭，以遠端提供全面、個人化的護理。儘管市場格局複雜且分散，但成長潛力強勁。為了利用這些機會，公司應專注於策略夥伴關係、技術整合和以患者為中心的服務交付。市場的本質是動態的，並隨著技術進步和監管變化而迅速發展，需要不斷創新和適應，以實現業務的持續成長和競爭的加劇。

市場動態：揭示快速發展的個人化醫療市場的關鍵市場洞察

供需的動態交互作用正在改變個人化醫療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加生物技術研究舉措並提高對遺傳學的了解
    • 快速採用針對複雜疾病的個人化治療策略
    • 政府支持措施，以提高對個人化醫療的認知和獲取
  • 市場限制因素
    • 實施個人化醫療的複雜性和缺乏熟練人員
  • 市場機會
    • 持續的研發活動以改善個人化醫療
    • 採用虛擬和數位策略進行個人化醫療的可能性
  • 市場問題
    • 可訪問性有限和準確性問題

波特五力：駕馭個人化醫療市場的策略工具

波特的五力架構是了解個人化醫療市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解個人化醫療市場的外部影響

外部宏觀環境因素在塑造個人化醫療市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解個人化醫療市場的競爭格局

個人化醫療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：個人化醫療市場供應商的績效評估

FPNV 定位矩陣是評估個人化醫療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃個人化醫療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，個人化醫療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 加強生物研究力度並提高對遺傳學的了解
      • 快速採用針對複雜疾病的個人化治療策略
      • 政府支持活動以提高對個人化醫療的認知和獲取
    • 抑制因素
      • 實施個人化醫療的複雜性和缺乏熟練人員
    • 機會
      • 持續的研發活動以改善個人化醫療
      • 採用虛擬和數位策略進行個人化醫療的可能性
    • 任務
      • 可訪問性限制和準確性問題
  • 市場區隔分析
    • 產品：引進個人化營養健康，提升身心健康意識
    • 應用：由於需要精準治療，個人化醫療在神經學的應用越來越多
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章個人化醫療市場：依產品

  • 介紹
  • 個人化醫療
    • 醫療資訊技術
    • 遠端醫療
  • 個性化醫療診斷
    • 直接面對消費者 (DTC) 診斷
    • 深奧化驗服務
    • 深奧的實驗室測試
    • 基因檢測
  • 個人化治療
    • 基因組醫學
    • 醫療設備
    • 製藥
  • 個人化營養與健康
    • 補充和替代醫學
    • 零售營養品

第7章個人化醫療市場：依應用分類

  • 介紹
  • 抗病毒藥
  • 心臟病學
  • 免疫學
  • 神經病學
  • 腫瘤學
  • 心理保健

第8章個人化醫療市場：依最終用戶分類

  • 介紹
  • 學術研究機構與實驗室
  • 生物與健康資訊公司
  • 合約研究組織
  • 診斷公司和檢測機構
  • 醫院和臨床護理

第9章美洲個人化醫療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太個人化醫療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲個人化醫療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 阿斯特捷利康收購 Fusion Pharmaceuticals 開發個人化癌症藥物
    • CurifyLabs 從 Mehta Heino Industries 收購關鍵 3D 列印 IP，以推進個人化醫療解決方案
    • 策略性收購增強諾華精準醫療能力
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Amgen, Inc.
  • AstraZeneca
  • Bayer Ag
  • BIOGEN INC.
  • Eli Lilly and Company
  • Exact Sciences Corporation
  • Exagen Inc
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • Glaxosmithkline Plc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Precision Biologics, Inc.
  • QIAGEN GmbH
  • Takeda Pharmaceutical Company Limited
Product Code: MRR-4D00F1312F65

The Personalized Medicine Market was valued at USD 542.10 billion in 2023, expected to reach USD 575.50 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 852.02 billion by 2030.

Personalized medicine (PM) represents a transformative approach in healthcare, focusing on tailoring treatments to individual genetic, environmental, and lifestyle factors. Its scope encompasses genomics, pharmacogenomics, and advanced diagnostics, essential for devising precise treatment plans. The necessity of personalized medicine grows with the rising patient demand for customized therapeutic solutions, increased prevalence of chronic diseases, and advancements in omics technologies. Application areas range from oncology, where targeted therapies offer new hope for cancer patients, to cardiovascular diseases and rare genetic disorders, each benefiting significantly from this personalized approach. End-use segments include hospitals, diagnostic labs, and research institutions, all of which leverage PM to enhance treatment outcomes and operational efficiencies.

KEY MARKET STATISTICS
Base Year [2023] USD 542.10 billion
Estimated Year [2024] USD 575.50 billion
Forecast Year [2030] USD 852.02 billion
CAGR (%) 6.67%

Key factors accelerating market growth include technological advancements, investment in research and development, and favorable regulatory frameworks promoting precision medicine initiatives. However, there are challenges such as high costs of genomic sequencing, data privacy concerns, and the complexity of integrating PM into traditional healthcare practices. Nevertheless, emerging opportunities abound, such as the integration of artificial intelligence and machine learning in processing large datasets for biomarker discovery, which can enhance predictive accuracy and treatment efficacy.

Innovative research areas include the development of cost-effective sequencing technologies and the exploration of microbiome influence on pharmacogenomics. Businesses can gain a competitive edge by investing in digital health solutions that combine PM with telemedicine, offering comprehensive, personalized care remotely. Despite being a complex and fragmented landscape, the personalized medicine market offers robust growth potential. To harness these opportunities, companies should focus on strategic partnerships, technological integration, and patient-centric approaches to service delivery. The nature of the market is dynamic, evolving rapidly with technological advancements and regulatory changes, necessitating continuous innovation and adaptation for sustained business growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Personalized Medicine Market

The Personalized Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in biotechnology research initiatives and improved understanding of genetics
    • Surge in the adoption of personalized treatment strategies for targeting complex diseases
    • Supportive government initiatives to raise awareness for and access to personalized medicine
  • Market Restraints
    • Complexities in the implementation of personalized medicine and lack of skilled personnel
  • Market Opportunities
    • Ongoing R&D activities for improvements in personalized medicines
    • Potential for the adoption of virtual and digital strategies for personalized medicine
  • Market Challenges
    • Limited accessibility and issues related to accuracy

Porter's Five Forces: A Strategic Tool for Navigating the Personalized Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Personalized Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Personalized Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Personalized Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Personalized Medicine Market

A detailed market share analysis in the Personalized Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Personalized Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Personalized Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Personalized Medicine Market

A strategic analysis of the Personalized Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, and Personalized Nutrition & Wellness. The Personalized Medical Care is further studied across Health Information Technology and Telemedicine. The Personalized Medicine Diagnostics is further studied across Direct-to-consumer (DTC) Diagnostics, Esoteric Lab Services, Esoteric Lab Tests, and Genetic Testing. The Personalized Medicine Therapeutics is further studied across Genomic Medicine, Medical Devices, and Pharmaceutical. The Personalized Nutrition & Wellness is further studied across Complementary & Alternative Medicine and Retail Nutrition.
  • Based on Application, market is studied across Antiviral, Cardiology, Immunology, Neurology, Oncology, and Psychiatry.
  • Based on End Users, market is studied across Academic Research Institutes & Research Laboratories, Bio & Health Informatics Companies, Contract Research Organizations, Diagnostic Companies & Testing Facilities, and Hospitals & Clinical Care.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
      • 5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
      • 5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
      • 5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited accessibility and issues related to accuracy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
    • 5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Personalized Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Personalized Medical Care
    • 6.2.1. Health Information Technology
    • 6.2.2. Telemedicine
  • 6.3. Personalized Medicine Diagnostics
    • 6.3.1. Direct-to-consumer (DTC) Diagnostics
    • 6.3.2. Esoteric Lab Services
    • 6.3.3. Esoteric Lab Tests
    • 6.3.4. Genetic Testing
  • 6.4. Personalized Medicine Therapeutics
    • 6.4.1. Genomic Medicine
    • 6.4.2. Medical Devices
    • 6.4.3. Pharmaceutical
  • 6.5. Personalized Nutrition & Wellness
    • 6.5.1. Complementary & Alternative Medicine
    • 6.5.2. Retail Nutrition

7. Personalized Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Antiviral
  • 7.3. Cardiology
  • 7.4. Immunology
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Psychiatry

8. Personalized Medicine Market, by End Users

  • 8.1. Introduction
  • 8.2. Academic Research Institutes & Research Laboratories
  • 8.3. Bio & Health Informatics Companies
  • 8.4. Contract Research Organizations
  • 8.5. Diagnostic Companies & Testing Facilities
  • 8.6. Hospitals & Clinical Care

9. Americas Personalized Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Personalized Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Personalized Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
    • 12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
    • 12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen, Inc.
  • 3. AstraZeneca
  • 4. Bayer Ag
  • 5. BIOGEN INC.
  • 6. Eli Lilly and Company
  • 7. Exact Sciences Corporation
  • 8. Exagen Inc
  • 9. F. Hoffmann-La Roche Ltd
  • 10. GE HealthCare Technologies Inc.
  • 11. Glaxosmithkline Plc.
  • 12. Illumina, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Laboratory Corporation of America Holdings
  • 15. Merck & Co., Inc.
  • 16. Novartis International AG
  • 17. Pfizer Inc.
  • 18. Precision Biologics, Inc.
  • 19. QIAGEN GmbH
  • 20. Takeda Pharmaceutical Company Limited

LIST OF FIGURES

  • FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONAL